Stockscreener 앱 받기
2.73
0.74%
0.02
시간 외 거래:
2.73
전일 마감가:
$2.71
열려 있는:
$2.7
하루 거래량:
435.99K
Relative Volume:
0.66
시가총액:
$195.83M
수익:
$405.47M
순이익/손실:
$53.66M
주가수익비율:
3.7917
EPS:
0.72
순현금흐름:
$131.28M
1주 성능:
+5.41%
1개월 성능:
+12.81%
6개월 성능:
-18.75%
1년 성능:
-33.58%
1일 변동 폭
$2.70
$2.79
1주일 범위
$2.61
$2.81
52주 변동 폭
$2.08
$4.22
Orasure Technologies Inc Stock (OSUR) Company Profile
명칭
Orasure Technologies Inc
전화
(503) 641-6115
주소
220 E FIRST ST, BETHLEHEM, PA
OSUR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OSUR
Orasure Technologies Inc
|
2.73 | 194.40M | 405.47M | 53.66M | 131.28M | 0.72 |
|
ISRG
Intuitive Surgical Inc
|
525.04 | 187.46B | 10.06B | 2.88B | 2.27B | 7.8807 |
|
BDX
Becton Dickinson Co
|
203.40 | 57.96B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
80.87 | 39.68B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
MDLN
Medline Inc
|
46.31 | 37.32B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
RMD
Resmed Inc
|
255.50 | 37.29B | 5.26B | 1.44B | 1.76B | 9.7713 |
Orasure Technologies Inc Stock (OSUR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-01-03 | 재개 | Evercore ISI | In-line |
| 2021-09-22 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2020-08-21 | 개시 | Evercore ISI | Outperform |
| 2020-08-10 | 개시 | Citigroup | Buy |
| 2020-08-10 | 개시 | JP Morgan | Neutral |
| 2020-08-07 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-06-25 | 개시 | Lake Street | Buy |
| 2020-04-21 | 재개 | Stephens | Equal-Weight |
| 2018-10-23 | 재개 | Raymond James | Mkt Perform |
| 2018-07-16 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2017-11-02 | 다운그레이드 | Jefferies | Buy → Hold |
| 2017-02-09 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2016-06-13 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2015-11-05 | 재확인 | Mizuho | Buy |
| 2015-05-07 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2015-01-23 | 재확인 | Mizuho | Buy |
| 2014-06-12 | 재확인 | Canaccord Genuity | Buy |
| 2014-06-11 | 재확인 | Mizuho | Buy |
| 2012-12-21 | 개시 | Mizuho | Buy |
| 2012-08-08 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2012-07-05 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2012-03-27 | 개시 | JMP Securities | Mkt Outperform |
모두보기
Orasure Technologies Inc 주식(OSUR)의 최신 뉴스
Aug Ideas: Is ATHM in a bullish channelEarnings Beat & Detailed Earnings Play Alerts - baoquankhu1.vn
OraSure files for FDA review of molecular self-test & Colli-Pee device - MSN
Risk Analysis: Does OraSure Technologies Inc. have a sustainable dividend2025 Retail Activity & Consistent Income Trade Recommendations - baoquankhu1.vn
Is OraSure Technologies Inc. stock attractive for growth ETFsPortfolio Value Report & Verified Short-Term Plans - bollywoodhelpline.com
Altai Capital nominates two directors to OraSure's board - MSN
The Truth About OraSure Technologies: Is This ‘Boring’ Test Maker Your Next Viral Money Play? - AD HOC NEWS
Altai Capital nominates two directors for OraSure Technologies board By Investing.com - Investing.com Nigeria
Altai Capital nominates two directors to OraSure board amid concerns By Investing.com - Investing.com Nigeria
Orasure Technologies confirms receipt of director nominations from Altai Capital - marketscreener.com
Orasure Technologies Confirms Receipt Of Director Nominations From Altai Capital - TradingView
OraSure (OSUR) Faces Board Nomination Challenge for 2026 - GuruFocus
Altai Capital nominates two directors for OraSure Technologies board - Investing.com
OraSure Technologies Confirms Altai Capital's Nominations for Board Election Ahead of 2026 Annual Meeting - Quiver Quantitative
OraSure Technologies Confirms Receipt of Director Nominations from Altai Capital - GlobeNewswire
Altai Capital nominates two directors to OraSure's board (update) (OSUR:NASDAQ) - Seeking Alpha
Altai Capital nominates two directors to OraSure board amid concerns - Investing.com
Altai pushes OraSure (NASDAQ: OSUR) board shakeup with two nominees at 2026 annual meeting - Stock Titan
Altai Capital Management Submits a Notice of its Intention to Nominate Candidates to OraSure Technologies Inc - marketscreener.com
Altai Capital Management Nominates Two Highly-Qualified Candidates for Election to OraSure Board of Directors - marketscreener.com
Aug Spikes: Is OraSure Technologies Inc stock undervalued vs historical averagesWeekly Stock Report & Weekly Consistent Profit Watchlists - Bộ Nội Vụ
Value Recap: Is OraSure Technologies Inc part of any major index2025 Major Catalysts & Accurate Trade Setup Notifications - baoquankhu1.vn
Movement Recap: Is OraSure Technologies Inc attractive for institutional investorsStop Loss & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
Aug Catalysts: How OraSure Technologies Inc stock trades before earnings2025 Short Interest & Safe Capital Growth Tips - Bộ Nội Vụ
Will OraSure Technologies Inc. stock deliver better than expected guidance2025 Technical Patterns & Consistent Return Strategy Ideas - Улправда
How OraSure Technologies Inc. stock trades before earningsJuly 2025 Sector Moves & Daily Volume Surge Trade Alerts - ulpravda.ru
OraSure submits CT/NG molecular self-test, Colli-Pee device for FDA review - MSN
OraSure Technologies (OSUR) Price - Zacks Investment Research
OraSure seeking FDA approval for pair of products - WFMZ.com
OraSure Files for FDA Review of Molecular Self-Test & Colli-Pee Device - sharewise.com
OraSure submits FDA applications for rapid STI test and collection device - Investing.com Nigeria
OraSure (OSUR) Seeks FDA Approval for New Diagnostic Solutions - GuruFocus
OraSure Seeks FDA Clearance for New STI Tests - TipRanks
OraSure submits FDA applications for rapid STI test and collection device By Investing.com - Investing.com South Africa
OraSure Technologies, Inc. Submits FDA Applications for Rapid Self-Test for STIs and At-Home Urine Collection Device - Quiver Quantitative
OraSure Submits CT/NG Molecular Self-Test and Colli-Pee™ Urine Collection Device for FDA Review - The Manila Times
OraSure Technologies Inc Submits FDA Applications for Diagnostic Devices - TradingView — Track All Markets
OraSure submits two diagnostic tests to FDA for clearance - StreetInsider
OraSure Technologies Stock Jump Looks Great, But How Secure Is That Gain? - Trefis
Is OraSure Technologies Inc. (EP3) stock good for long term investingJuly 2025 Catalysts & Consistent Profit Trade Alerts - Улправда
Investment Recap: Can OraSure Technologies Inc. stock surprise with earnings upsideWeekly Risk Report & Daily Chart Pattern Signal Reports - Улправда
Can OraSure Technologies Inc. stock maintain operating margins2025 Technical Patterns & Low Risk High Reward Ideas - Улправда
Can OraSure Technologies Inc. stock surprise with earnings upsideJuly 2025 Catalysts & Low Risk High Reward Ideas - Улправда
Hedge fund confirms boardroom battle brewing at OraSure - WFMZ.com
Report: Businessman upping pressure amid buyout attempt of OraSure - wfmz.com
OraSure Technologies Earnings Notes - Trefis
OraSure Technologies Issues Statement Regarding Altai Capital?s Intent to Nominate Director Candidates - marketscreener.com
OraSure issues statement regarding Altai's intent to nominate director candidates - marketscreener.com
OraSure (OSUR) Responds to Altai Capital's Board Nominee Proposa - GuruFocus
Altai Capital to nominate directors to OraSure board amid concerns By Investing.com - Investing.com Nigeria
Altai Capital to nominate two board candidates at OraSure Technologies By Investing.com - Investing.com Nigeria
OraSure Confirms Altai Capital's Intention of Board Nominations - marketscreener.com
Orasure Technologies Inc (OSUR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.36%
0.01%
자본화:
|
볼륨(24시간):